Abstract
Intraperitoneal (IP) insulin treatment has been proposed as an alternative approach to conventional subcutaneous (SC) insulin therapy. The rationale for doing that is in the partial portal insulin absorption producing more physiologic plasma insulin kinetics. Both external and implantable devices have been used for IP insulin administration. This study analyzed the clinical feasibility and therapeutic efficacy of a chronic IP insulin treatment by means of an implantable constant rate insulin infusion pump.
| Original language | English |
|---|---|
| Pages (from-to) | 1687-1688 |
| Number of pages | 2 |
| Journal | Transplantation Proceedings |
| Volume | 18 |
| Issue number | 6 |
| Publication status | Published - 1986 |
Fingerprint
ASJC Scopus subject areas
- Surgery
- Transplantation
Cite this
Implantable devices for constant rate intraperitoneal insulin administration : 1 year follow-up. / Librenti, M. C.; Monti, L. D.; Galimberti, G.
In: Transplantation Proceedings, Vol. 18, No. 6, 1986, p. 1687-1688.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Implantable devices for constant rate intraperitoneal insulin administration
T2 - 1 year follow-up
AU - Librenti, M. C.
AU - Monti, L. D.
AU - Galimberti, G.
PY - 1986
Y1 - 1986
N2 - Intraperitoneal (IP) insulin treatment has been proposed as an alternative approach to conventional subcutaneous (SC) insulin therapy. The rationale for doing that is in the partial portal insulin absorption producing more physiologic plasma insulin kinetics. Both external and implantable devices have been used for IP insulin administration. This study analyzed the clinical feasibility and therapeutic efficacy of a chronic IP insulin treatment by means of an implantable constant rate insulin infusion pump.
AB - Intraperitoneal (IP) insulin treatment has been proposed as an alternative approach to conventional subcutaneous (SC) insulin therapy. The rationale for doing that is in the partial portal insulin absorption producing more physiologic plasma insulin kinetics. Both external and implantable devices have been used for IP insulin administration. This study analyzed the clinical feasibility and therapeutic efficacy of a chronic IP insulin treatment by means of an implantable constant rate insulin infusion pump.
UR - http://www.scopus.com/inward/record.url?scp=0022878346&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0022878346&partnerID=8YFLogxK
M3 - Article
VL - 18
SP - 1687
EP - 1688
JO - Transplantation Proceedings
JF - Transplantation Proceedings
SN - 0041-1345
IS - 6
ER -